Literature DB >> 35524087

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

Martha E Teke1, Amber Leila Sarvestani1, Jonathan M Hernandez2, Hiran C Fernando3, Robert D Timmerman4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35524087     DOI： 10.1245/s10434-022-11584-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.

Authors:  Robert D Timmerman; Rebecca Paulus; Harvey I Pass; Elizabeth M Gore; Martin J Edelman; James Galvin; William L Straube; Lucien A Nedzi; Ronald C McGarry; Cliff G Robinson; Peter B Schiff; Garrick Chang; Billy W Loo; Jeffrey D Bradley; Hak Choy
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

2.  Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Authors:  Nasser K Altorki; Xiaofei Wang; Dennis Wigle; Lin Gu; Gail Darling; Ahmad S Ashrafi; Rodney Landrenau; Daniel Miller; Moishe Liberman; David R Jones; Robert Keenan; Massimo Conti; Gavin Wright; Linda J Veit; Suresh S Ramalingam; Mohamed Kamel; Harvey I Pass; John D Mitchell; Thomas Stinchcombe; Everett Vokes; Leslie J Kohman
Journal:  Lancet Respir Med       Date:  2018-11-12       Impact factor: 30.700

3.  Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.

Authors:  Jing Wu; Harrison X Bai; Lilian Chan; Chang Su; Paul J Zhang; Li Yang; Zishu Zhang
Journal:  J Thorac Cardiovasc Surg       Date:  2019-12-26       Impact factor: 5.209

Review 4.  Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer.

Authors:  Christopher Cao; Sunil Gupta; David Chandrakumar; David H Tian; Deborah Black; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 5.  Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.

Authors:  Daniel J Tandberg; Betty C Tong; Bradley G Ackerson; Chris R Kelsey
Journal:  Cancer       Date:  2017-12-19       Impact factor: 6.860

6.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

Authors:  Pia Baumann; Jan Nyman; Morten Hoyer; Berit Wennberg; Giovanna Gagliardi; Ingmar Lax; Ninni Drugge; Lars Ekberg; Signe Friesland; Karl-Axel Johansson; Jo-Asmund Lund; Elisabeth Morhed; Kristina Nilsson; Nina Levin; Merete Paludan; Christer Sederholm; Anders Traberg; Lena Wittgren; Rolf Lewensohn
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544
  6 in total
  2 in total

1.  Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety.

Authors:  Hong-Tao Hu; Xiao-Hui Zhao; Chen-Yang Guo; Quan-Jun Yao; Xiang Geng; Wen-Bo Zhu; Hong-Le Li; Wei-Jun Fan; Hai-Liang Li
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

2.  Resect a little, resect more, irradiate or ablate-what is the best approach?

Authors:  Conor M Maxwell; Hiran C Fernando
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.